These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27387758)

  • 1. Early changes in the metabolic profile of activated CD8(+) T cells.
    Cammann C; Rath A; Reichl U; Lingel H; Brunner-Weinzierl M; Simeoni L; Schraven B; Lindquist JA
    BMC Cell Biol; 2016 Jul; 17(1):28. PubMed ID: 27387758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulators of Glucose Metabolism in CD4
    Palmer CS; Hussain T; Duette G; Weller TJ; Ostrowski M; Sada-Ovalle I; Crowe SM
    Int Rev Immunol; 2016 Nov; 35(6):477-488. PubMed ID: 26606199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism.
    Liu Y; Zhao Y; Guo L
    Mol Cell Endocrinol; 2016 Jan; 420():208-16. PubMed ID: 26549689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic plasticity of human T cells: Preserved cytokine production under glucose deprivation or mitochondrial restriction, but 2-deoxy-glucose affects effector functions.
    Renner K; Geiselhöringer AL; Fante M; Bruss C; Färber S; Schönhammer G; Peter K; Singer K; Andreesen R; Hoffmann P; Oefner P; Herr W; Kreutz M
    Eur J Immunol; 2015 Sep; 45(9):2504-16. PubMed ID: 26114249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch.
    Gubser PM; Bantug GR; Razik L; Fischer M; Dimeloe S; Hoenger G; Durovic B; Jauch A; Hess C
    Nat Immunol; 2013 Oct; 14(10):1064-72. PubMed ID: 23955661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligomeric Procyanidins Interfere with Glycolysis of Activated T Cells. A Novel Mechanism for Inhibition of T Cell Function.
    Goto M; Wakagi M; Shoji T; Takano-Ishikawa Y
    Molecules; 2015 Oct; 20(10):19014-26. PubMed ID: 26492229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-Like Receptor 7 Activation Enhances CD8+ T Cell Effector Functions by Promoting Cellular Glycolysis.
    Li Q; Yan Y; Liu J; Huang X; Zhang X; Kirschning C; Xu HC; Lang PA; Dittmer U; Zhang E; Lu M
    Front Immunol; 2019; 10():2191. PubMed ID: 31572396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic phenotype of bladder cancer.
    Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
    Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of CD44 induces glycolysis-to-oxidative phosphorylation transition via modulation of the c-Src-Akt-LKB1-AMPKα pathway.
    Nam K; Oh S; Shin I
    Biochem J; 2016 Oct; 473(19):3013-30. PubMed ID: 27458252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells.
    Caro-Maldonado A; Wang R; Nichols AG; Kuraoka M; Milasta S; Sun LD; Gavin AL; Abel ED; Kelsoe G; Green DR; Rathmell JC
    J Immunol; 2014 Apr; 192(8):3626-36. PubMed ID: 24616478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
    PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway.
    Zhang X; Ai Z; Chen J; Yi J; Liu Z; Zhao H; Wei H
    Mol Med Rep; 2017 Apr; 15(4):1869-1876. PubMed ID: 28259993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions.
    Menk AV; Scharping NE; Moreci RS; Zeng X; Guy C; Salvatore S; Bae H; Xie J; Young HA; Wendell SG; Delgoffe GM
    Cell Rep; 2018 Feb; 22(6):1509-1521. PubMed ID: 29425506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
    Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
    PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines.
    Fiume L; Manerba M; Vettraino M; Di Stefano G
    Pharmacology; 2010; 86(3):157-62. PubMed ID: 20699632
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kirchmair A; Nemati N; Lamberti G; Trefny M; Krogsdam A; Siller A; Hörtnagl P; Schumacher P; Sopper S; Sandbichler A; Zippelius A; Ghesquière B; Trajanoski Z
    Front Immunol; 2023; 14():1267816. PubMed ID: 37928527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTORC1 regulates CD8+ T-cell glucose metabolism and function independently of PI3K and PKB.
    Finlay DK
    Biochem Soc Trans; 2013 Apr; 41(2):681-6. PubMed ID: 23514176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased glycolytic metabolism contributes to but is not the inducer of apoptosis following IL-3-starvation.
    Gonin-Giraud S; Mathieu AL; Diocou S; Tomkowiak M; Delorme G; Marvel J
    Cell Death Differ; 2002 Oct; 9(10):1147-57. PubMed ID: 12232803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-7 Restores T Lymphocyte Immunometabolic Failure in Septic Shock Patients through mTOR Activation.
    Venet F; Demaret J; Blaise BJ; Rouget C; Girardot T; Idealisoa E; Rimmelé T; Mallet F; Lepape A; Textoris J; Monneret G
    J Immunol; 2017 Sep; 199(5):1606-1615. PubMed ID: 28724580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-33 activates mTORC1 and modulates glycolytic metabolism in CD8
    Liang Y; Wang X; Wang H; Yang W; Yi P; Soong L; Cong Y; Cai J; Fan X; Sun J
    Immunology; 2022 Jan; 165(1):61-73. PubMed ID: 34411293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.